4//SEC Filing
Watkin Jared 4
Accession 0001415889-23-003072
CIK 0000001800other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 7:24 PM ET
Size
8.2 KB
Accession
0001415889-23-003072
Insider Transaction Report
Form 4
Watkin Jared
Senior Vice President
Transactions
- Award
Option (right to buy)
2023-02-17+45,812→ 45,812 totalExercise: $106.24From: 2024-02-17Exp: 2033-02-16→ Common Shares (45,812 underlying) - Award
Common shares without par value
2023-02-17+11,617→ 78,162 total
Holdings
- 652(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 17, 2023.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,270 on February 17, 2024, 15,271 on February 17, 2025, and 15,271 on February 17, 2026.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001645118
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 7:24 PM ET
- Size
- 8.2 KB